Literature DB >> 24692463

Pathophysiological relationships between heart failure and depression and anxiety.

Deborah W Chapa, Bimbola Akintade, Heesook Son, Patricia Woltz, Dennis Hunt, Erika Friedmann, Mary Kay Hartung, Sue Ann Thomas.   

Abstract

Depression and anxiety are common comorbid conditions in patients with heart failure. Patients with heart failure and depression have increased mortality. The association of anxiety with increased mortality in patients with heart failure is not established. The purpose of this article is to illustrate the similarities of the underlying pathophysiology of heart failure, depression, and anxiety by using the Biopsychosocial Holistic Model of Cardiovascular Health. Depression and anxiety affect biological processes of cardiovascular function in patients with heart failure by altering neurohormonal function via activation of the hypothalamic-pituitary-adrenal axis, autonomic dysregulation, and activation of cytokine cascades and platelets. Patients with heart failure and depression or anxiety may exhibit a continued cycle of heart failure progression, increased depression, and increased anxiety. Understanding the underlying pathophysiological relationships in patients with heart failure who experience comorbid depression and/or anxiety is critical in order to implement appropriate treatments, educate patients and caregivers, and educate other health professionals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24692463     DOI: 10.4037/ccn2014938

Source DB:  PubMed          Journal:  Crit Care Nurse        ISSN: 0279-5442            Impact factor:   1.708


  10 in total

Review 1.  Depression, Anxiety, and Cognitive Impairment : Comorbid Mental Health Disorders in Heart Failure.

Authors:  Christiane E Angermann; Georg Ertl
Journal:  Curr Heart Fail Rep       Date:  2018-12

2.  Neural correlates of heart-focused interoception: a functional magnetic resonance imaging meta-analysis.

Authors:  Stefan M Schulz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-10-10       Impact factor: 6.237

3.  Psychiatric Comorbidity and Psychosocial Factors Matter in Heart Failure.

Authors:  Ching-Yen Chen; Chun-Li Wang
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

Review 4.  Post-translational regulation of neuronal nitric oxide synthase: implications for sympathoexcitatory states.

Authors:  Neeru M Sharma; Kaushik P Patel
Journal:  Expert Opin Ther Targets       Date:  2016-12-02       Impact factor: 6.902

5.  Age-dependent changes in cardiac performance, motor function, QoL, and mental status in metoprolol-treated chronic heart failure patients.

Authors:  Qiuhong Shu; Liyong Wu; Ran Zhang; Qian Zhang; Jingjing Huang; Yong Meng
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

6.  Sex-dependent changes in physical, mental, and quality of life outcomes in metoprolol-treated Chinese chronic heart failure patients.

Authors:  Liyong Wu; Qian Zhang; Qiuhong Shu; Ran Zhang; Yong Meng
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

7.  Cognitive performance is associated with worse prognosis in patients with heart failure with reduced ejection fraction.

Authors:  Patrícia Fino; Rita Matos Sousa; Renata Carvalho; Nuno Sousa; Filipa Almeida; Vítor Hugo Pereira
Journal:  ESC Heart Fail       Date:  2020-08-21

8.  Mindfulness, Anxiety Symptoms, and Quality of Life in Heart Failure.

Authors:  Kaitlyn Rechenberg; Lakeshia Cousin; Laura Redwine
Journal:  J Cardiovasc Nurs       Date:  2020 Jul/Aug       Impact factor: 2.468

9.  Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study.

Authors:  XiaoLiang Cheng; Min Zhu; Qing Liu; Zhenxia Feng; Yong Meng
Journal:  Drug Des Devel Ther       Date:  2020-08-25       Impact factor: 4.162

10.  Can Religiosity and Social Support Explain Effects of Trait Emotional Intelligence on Health-Related Quality of Life: A Cross-Cultural Study.

Authors:  Hina Ghafoor; Peter Nordbeck; Oliver Ritter; Paul Pauli; Stefan M Schulz
Journal:  J Relig Health       Date:  2021-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.